Gurugram: Global Health Limited, which operates Medanta Hospitals, one of the largest private multi-specialty tertiary care providers in North and East India, has announced its unaudited consolidated financial results for the quarter ending December 31, 2024. The company delivered a robust performance, driven by higher patient volumes, steady growth across its hospitals, and strategic expansion efforts.
Medanta’s total income for Q3 FY2025 stood at Rs 9,595 million, reflecting a year-on-year growth of 12.3 per cent. EBITDA for the quarter reached Rs 2,538 million, registering an 8.4 per cent increase, with EBITDA margins at 26.5 per cent.
Profit after tax (PAT) saw a significant rise of 15.6 per cent to Rs 1,429 million, with PAT margins improving to 14.9 per cent from 14.5 per cent in the same quarter last year. The hospital chain witnessed strong patient inflows, with average occupied bed days growing by 10.5 per cent, translating to an occupancy rate of 63.6 per cent on an increased bed capacity.
Average revenue per occupied bed (ARPOB) grew marginally by 1.2 per cent year-on-year to Rs 61,307. In-patient volumes saw a 12.9 per cent growth, while out-patient volumes increased by 8.7 per cent. Revenue from matured hospitals touched Rs 6,466 million, growing by 10.1 per cent year-on-year, with EBITDA rising by 9.0 per cent. Developing hospitals also showed steady progress, generating Rs 3,004 million in revenue, up 9.5 per cent, while EBITDA increased by 4.8 per cent.
International patient revenue experienced a notable jump of 14.3 per cent to Rs 541 million. Meanwhile, Medanta’s out-patient pharmacy segment continued to perform well, with total revenue from hospital and retail pharmacies increasing by 21.4 per cent from Rs 290 million in Q3 FY2024 to Rs 352 million in Q3 FY2025.
Commenting on the results, Pankaj Sahni, Group CEO and Director of Medanta, expressed confidence in the company’s continued momentum. He emphasised that the growth was fueled by higher patient volumes and strong contributions from developing hospitals. He also announced an expansion initiative in Ranchi, where Medanta has signed a long-term lease agreement to operate and manage a newly built 110-bed hospital.
As part of this strategic expansion, the Board of Directors has approved the lease for a facility spanning 1.33 acres, with a built-up area of 108,000 sq. ft. The hospital, equipped with advanced OT setups and high-end medical equipment, is expected to commence operations by the end of Q1 FY2026. Medanta will enter into a 15-year lease, with the option to extend for two additional 15-year terms at its discretion. The new facility is strategically located just 1.2 km from the existing Medanta Ranchi hospital, ensuring seamless integration and operational synergies. Designed primarily for high-end tertiary care, it will address a critical gap in specialized medical services currently unmet at Medanta Ranchi.
In infrastructure expansion, 34 new beds were added across Medanta facilities during the quarter, taking the total additions to 219 beds in the first nine months of FY2025. The hospital group also strengthened its medical team, onboarding 49 new doctors in Q3, bringing the total number of new recruitments in 9M FY2025 to 101.